电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

Fc gamma RII (CD32) (AA 34-216) protein (His tag)

CD32 宿主: 人 宿主: 大肠杆菌(E. Coli) Recombinant Greater than 95 % as determined by SDS-PAGE ELISA, WB
产品编号 ABIN7122903
发货至: 中国
  • 抗原 See all Fc gamma RII (CD32) 蛋白
    Fc gamma RII (CD32)
    蛋白类型
    Recombinant
    产品特性
    AA 34-216
    宿主
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    资源
    • 5
    • 2
    • 2
    • 1
    • 1
    大肠杆菌(E. Coli)
    标记
    His tag
    应用范围
    ELISA, Western Blotting (WB)
    纯度
    Greater than 95 % as determined by SDS-PAGE
    过滤
    0.2 μm filtered
    Top Product
    Discover our top product CD32 蛋白
  • 应用备注
    Optimal working dilution should be determined by the investigator.
    限制
    仅限研究用
  • 状态
    Lyophilized
    溶解方式
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    缓冲液
    Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4
    储存条件
    4 °C,-20 °C
    储存方法
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    有效期
    12 months
  • 抗原
    Fc gamma RII (CD32)
    别名
    CD32 (CD32 产品)
    别名
    CD32 Protein, CD32B Protein, FCG2 Protein, FCGR2 Protein, IGFR2 Protein, FCGR2B Protein, AI528646 Protein, F630109E10Rik Protein, Fc[g]RII Protein, FcgRII Protein, Fcgr2 Protein, Fcgr2a Protein, Fcr-2 Protein, Fcr-3 Protein, Ly-17 Protein, Ly-m20 Protein, LyM-1 Protein, Lym-1 Protein, FCRII Protein, FcRII Protein, Fc fragment of IgG receptor IIb Protein, Fc receptor, IgG, low affinity IIb Protein, FCGR2B Protein, Fcgr2b Protein
    背景
    CD32, CD32A, CD32B, CD32C, CDw32, Fc fragment of IgG low affinity IIa receptor, Fc fragment of IgG low affinity IIa receptor for (CD32), Fc fragment of IgG low affinity IIb receptor, Fc fragment of IgG low affinity IIb receptor for (CD32), Fc fragment of IgG low affinity IIc receptor
    分子量
    20 kDa
You are here: